The role of Bruton's tyrosine kinase inhibitors in the management of mantle cell lymphoma. (Record no. 30846818)

MARC details
000 -LEADER
fixed length control field 01640 a2200373 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518095016.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202010s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1477-092X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1177/1078155220915956
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Hanna, Kirollos S
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20201027
245 00 - TITLE STATEMENT
Title The role of Bruton's tyrosine kinase inhibitors in the management of mantle cell lymphoma.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Date of publication, distribution, etc. Jul 2020
300 ## - PHYSICAL DESCRIPTION
Extent 1190-1199 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adenine
General subdivision analogs & derivatives
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Agammaglobulinaemia Tyrosine Kinase
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Benzamides
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunotherapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lymphoma, Mantle-Cell
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Piperidines
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein Kinase Inhibitors
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrazines
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrazoles
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrimidines
General subdivision administration & dosage
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Campbell, Maren
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Husak, Alex
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sturm, Sabrina
773 0# - HOST ITEM ENTRY
Title Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Related parts vol. 26
-- no. 5
-- p. 1190-1199
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1177/1078155220915956">https://doi.org/10.1177/1078155220915956</a>
Public note Available from publisher's website

No items available.